MarketBeatSat, 06 Jun 2026 07:12:44 GMTBioCryst Pharmaceuticals Backs ORLADEYO Outlook as Navenibart Trial AdvancesBCRX+2.35%
Seeking AlphaTue, 12 May 2026 23:20:48 GMTBioCryst Pharmaceuticals, Inc. (BCRX) Presents at Bank of America Global Healthcare Conference 2026 TranscriptBCRX+2.35%
BenzingaThu, 07 May 2026 17:46:12 GMTThese Analysts Revise Their Forecasts On BioCryst Pharma After Q1 EarningsBCRX+2.35%
Seeking AlphaWed, 06 May 2026 16:11:21 GMTBioCryst Pharmaceuticals, Inc. (BCRX) Q1 2026 Earnings Call TranscriptBCRX+2.35%
Zacks Investment ResearchWed, 06 May 2026 14:30:39 GMTBioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Beats Revenue EstimatesBCRX+2.35%
